{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-22-025922","form_type":"8-K","ticker":"ABCL","cik":"0001703057","company_name":"AbCellera Biologics Inc.","filed_at":"2022-07-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.710130+00:00","generated_at":"2026-06-24T12:25:21.379114+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"AbCellera CBO Neil Berkley departs; separation deal includes salary continuation, equity acceleration","bullets":["Neil Berkley left as Chief Business Officer effective June 29, 2022.","Receives 12 months base salary ($450,000/yr) paid over 12 months, plus $173,710 cash payment.","AbCellera accelerates vesting of 17,500 RSUs; shares issued on Aug 11, 2022 after trading restriction.","Company pays COBRA premiums through July 1, 2023 or earlier if new job obtained.","Separation agreement includes non-disparagement, non-solicitation, and confidentiality covenants."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-22-025922","json":"https://secwatch.observer/filing/0001564590-22-025922.json","markdown":"https://secwatch.observer/filing/0001564590-22-025922.md","text":"https://secwatch.observer/filing/0001564590-22-025922.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1703057/000156459022025922/0001564590-22-025922-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1703057/000156459022025922/abcl-8k_20220709.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T12:25:21.379114+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"fd8af961eb","claim":"Neil Berkley departed as Chief Business Officer at AbCellera Biologics Inc..","evidence_excerpt":"the departure of Neil Berkley, its Chief Business Officer, from the Company effective June 29, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1703057/000156459022025922/0001564590-22-025922-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"departed"},{"label":"Role","value":"Chief Business Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}